Boston – October 18, 2020
Continuous process first gained pharma and biotech’s attention in early 2010. It has taken Vertex and Janssen years before Symdeko and PREZISTA approved by the FDA under continuous manufacturing respectively. The last 4 years we have seen a lot more pilot projects, regulatory filings and investments in this area that continuous manufacturing is bound to be the game changer to drug developers in 2020.
The Commercializing Continuous Processing community was established in 2017 and grows substantially with a global audience. Chaired by Lawrence de Belder, Senior Principal Engineer of Continuous Manufacturing, Janssen, the 4th annual CCP Summit will return to Boston on January 28 – 30 – gathering more than 130 experts in both small molecules and biologics to discuss their latest transformation journeys and challenges.
As the only dedicated community to continuous processing commercialization, the 2020 agenda is packed with exciting fresh content:
- FDA’s CBER will update you on their latest Complex Biologics Products Manufacturing initiatives, and how you can secure early regulatory engagement to drive smooth approval
- CPI UK and AstraZeneca will share their PROSPECT project in the UK, which has just announced their latest plan of funding a direct compression platform for CM of oral solid dosage drugs in the UK
- Janssen and University of Ghent will reveal their research on continuous freeze drying and why it makes economic sense for biologics
- Merck, USP will explain the ICH Q13 draft guidance and how this can enable your continuous manufacturing quality
- Amgen, Codiak Biosciences, Pfizer, Bristol-Myers Squibb, Eli Lilly, ImmunoGen, AbbVie will release their latest data from virtual plant simulation to exosomes continuous processing to real time PAT control
This is the must-attend and dedicated continuous manufacturing for pharma, biotechs and leading solution providers to help transform the pharma manufacturing world.
Confirmed attending organizations include: Alkermes, Amgen, BMS, Pfizer, C-SOPS, Janssen, Greenleaf Health, Mersana Therapeutics and many others..
Supported by: Emerson, Seeq, Asymchem, Purolite, Sartorius Stedim Biotech
For more information, please visit: https://continuous-processing-pharma.com/
Contact:
Marketing Manager: Caroline Hunt
Email: info@hansonwade.com
T: +1 617 455 4188